Animal-free cell therapy from Aachen secures global growth

PL BioScience closes Series A financing in the amount of 7.8 million euros

09-Aug-2024 - PL BioScience GmbH has successfully completed a Series A financing round. The growth financing round attracted significant investments from AVANT BIO (New York), LePure Biotech (Shanghai), b.value AG (Dortmund) and better ventures (Munich). The four partners contribute their experience in deep ...

Merck Invests More Than € 300 Million in New Life Science Research Center in Germany

Research center to accelerate biopharmaceutical product development

26-Apr-2024 - Merck, a leading science and technology company, is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the Life Science business sector will research solutions for manufacturing antibodies, mRNA ...

Capricorn Scientific and ExcellGene Form Strategic Partnership to Support Biotech Industries

This customer-oriented approach is dedicated to accelerating the biotech journey from R&D up to clinical production

29-Feb-2024 - Capricorn Scientific GmbH and ExcellGene SA have established a strategic partnership within the biotechnology sector. Applying their collective expertise and capabilities, the collaboration seeks to help customers by optimizing processes, developing products, and offering solutions in ...

BMH invests in developer of sustainable cell cultivation systems

Green Elephant Biotech closes pre-seed funding round

15-Feb-2022 - Beteiligungs-Managementgesellschaft Hessen mbH ("BMH"), the medium-sized investment and venture capital company of the State of Hesse, is investing in Green Elephant Biotech GmbH. In addition to the lead investor BMH, a consortium of industry-experienced business angels also participated in the ...

Sartorius acquires majority stake in CellGenix

Portfolio expanded by cell culture components, such as growth factors, cytokines, and media

05-Jul-2021 - The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer CellGenix GmbH. The company based in Freiburg, Germany, and with a sales subsidiary near the biotechnology hub in Boston, Massachusetts USA, produces and ...

Cytiva acquires Intermountain Life Sciences

Double capacity for buffers and liquid cell culture media

02-Jul-2021 - Cytiva has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture media. Cytiva will use Intermountain’s manufacturing site in Utah to rapidly boost its liquid cell culture production by millions of liters. Hiring is ongoing to rapidly increase ...

denovoMATRIX receives seed financing

13-Dec-2018 - denovoMATRIX develops and manufactures biomimetic coatings for stem cell culture. With its technology, the team of denovoMATRIX enables cutting edge research in the stem cell field, and aims to revolutionize cell culture processes in Life Science research. The HTGF together with TGFS are ...

INTEGRA Biosciences Opens German Subsidiary

23-Mar-2015 - Following on from the successful launch of subsidiaries in France, the UK and the USA - INTEGRA Biosciences has announced the opening in January 2015 of a new organisation based in Konstanz, Germany.Leveraging an existing knowledgeable local sales and service team – INTEGRA Biosciences ...

TAP Biosystems Group plc shareholders approve Sartorius’ takeover offer

25-Nov-2013 - The shareholders of UK company TAP Biosystems Group plc approved Sartorius’ takeover offer. The cash offer made through Sartorius’ wholly-owned subsidiary Sartorius Stedim Biotech GmbH valued TAP Biosystems Group plc at approximately €33 million. The transaction is expected to close at the end of ...

analytica presents biotechnology highlights

26-Mar-2012 - From molecular-biology techniques to forensic DNA analysis: from April 17 – 20 analytica features in-depth information about the latest methods and techniques in laboratory technology, analysis and biotechnology. One of the five halls, hall A3, is devoted entirely to the biotech industry. The ...